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MicroRNAs (miRNAs) modulate a broad range of gene
expression patterns during development and tissue homeo-
stasis, and in the pathogenesis of disease. The exquisite
spatio–temporal control of miRNA abundance is made pos-
sible, in part, by regulation of the miRNA biogenesis path-
way. In this review, we discuss two emerging paradigms for
post-transcriptional control of miRNA expression. One par-
adigm centers on the Microprocessor, the protein complex
essential for maturation of canonical miRNAs. The second
paradigm is specific to miRNA families, and requires inter-
action between RNA-binding proteins and cis-regulatory se-
quences within miRNA precursor loops.
The microRNA (miRNA) biogenesis pathway is a series
of biochemical steps that converts the primary miRNA
transcript (pri-miRNA) to the biologically active, mature
miRNA (Kim et al. 2009). The characterized first step
is the recognition of the canonical stem–loop structure of
the miRNA by the Microprocessor complex. This leads
to ribonucleolytic cleavage of the pri-miRNA, removal of
the flanking sequences, and liberation of the stem–loop
precursor miRNA (pre-miRNA). The pre-miRNA is ex-
ported to the cytoplasm via the Exportin5 pathway. The
precursor is then cleaved by the ribonuclease enzyme
Dicer. This leads to an ;22-nucleotide duplex, one strand
of which is loaded into the Argonaute-containing RNA-
induced silencing complex (RISC). This represents the
endpoint of biogenesis; the single-stranded mature
miRNA is ready to guide mRNA binding, which leads
to translational repression and/or mRNA destabilization
(Kim et al. 2009). As an exception to this rule, the less
abundant ‘‘mirtrons’’ circumnavigate Drosha processing
and are processed only by Dicer (Okamura et al. 2008).
In principle, miRNA abundance could be controlled at
transcription of the pri-miRNA, during any of the bio-
genesis steps, or at turnover of the mature miRNA.
Control at transcription is well established. Most miRNAs
are transcribed by RNA polymerase II, and their upstream
regulatory regions contain canonical core promoters and
enhancers (Lee and Dutta 2009). Early studies by several
laboratories, however, found that mature miRNA expres-
sion does not always correlate with expression of the pri-
miRNA (Obernosterer et al. 2006; Thomson et al. 2006;
Blenkiron et al. 2007; Wulczyn et al. 2007). Thus, miRNAs
themselves must be post-transcriptionally regulated. In
fact, regulation at multiple biogenesis steps and at turn-
over of the mature miRNA has now been established
(Hwang et al. 2007; for review, see Pawlicki and Steitz
2009). This review focuses on the regulation of miRNA
production during biogenesis. The majority of discoveries
on miRNA regulation can be distilled down to two con-
trasting paradigms based on the biochemical point of
regulation: at the Microprocessor complex, and at the ter-
minal loop of specific miRNA precursors.
Multiple regulatory events converge
on the Microprocessor complex
As the first processing step in miRNA biogenesis, the
Microprocessor is positioned to play a pivotal role in the
regulation of mature miRNA abundance. This complex is
minimally composed of two proteins: the dsRNA-binding
protein DGCR8 (Pasha), and the RNase III enzyme
Drosha (Lee et al. 2003; Denli et al. 2004; Gregory et al.
2004; Han et al. 2004; Landthaler et al. 2004). These two
proteins represent the essential requirements for the first
processing step, defined by reconstitution of activity with
purified recombinant proteins. In human cell extracts,
however, Drosha has been described to reside in multiple
complexes (Gregory et al. 2004). A complex that is
comprised solely of Drosha and DGCR8 has robust pri-
miRNA processing activity. A second, larger complex has
multiple accessory proteins, yet also has pri-miRNA
processing activity. It is not clear whether this large com-
plex is assembled around RNAs, since many of the ac-
cessory factors contain RNA interaction motifs, and
RNase treatment of extracts has been shown to shift
the size of the Drosha complex (Han et al. 2004). The ac-
cessory proteins in this large Drosha complex include
the EWSR1, Fus, numerous heterogenous nuclear RNA
complex (hnRNP) proteins, and the DEAD-box helicases
p68(DDX5) and p72(DDX17). While the exact biochemical
composition of the cellular Microprocessor is unknown,
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a recent collection of studies implicates p68 and p72 as
important cofactors of the Microprocessor in vivo.
Integrating signal transduction with Drosha
processing: the role of p68 and p72
The p68 and p72 helicases are conserved across eukary-
otes and are implicated in diverse RNA processing
pathways (for review, see Fuller-Pace 2006). In cell-free
assays, both proteins have moderately processive ATP-
dependent RNA unwinding and annealing activities. In
cells, the proteins have been linked to several pathways—
most notably splicing and transcription. p68 was isolated
as a component of the spliceosome, and specifically is re-
quired for proper assembly–disassembly of the U1 59 splice
site. Interestingly, p68 and p72 interact with several com-
ponents of the transcriptional machinery, including RNA
polymerase II and CBP/p300. This raises the interesting
possibility that one role of p68 is to coordinate/colocalize
the splicing machinery with the transcription apparatus.
Independent of this, p68 acts as a transcriptional cofactor
for several factors, including CBP/p300, p53, and the es-
trogen receptor a (ERa). For example, etoposide-mediated
induction of p53-responsive genes is dependent on p68.
Remarkably, this requirement is not dependent on p68
helicase activity, as an ATPase mutant allele of p68 res-
cued induction by p53. RNA binding, however, was still
required. Similarly, ERa coactivation is not dependent
on helicase activity. This suggests a model whereby p68
and possibly p72 mediate assembly of transcription com-
plexes at promoters and recruit the splicing machinery
to the promoter, thus facilitating cotranscriptional splicing
events.
Recently, p68 and p72 were implicated as regulators
of processing for many miRNAs (Fukuda et al. 2007).
This was first demonstrated in studies on mice that are
homozygous null for either p68 or p72. For both genes,
loss of function is lethal; p68-null mice die at embryonic
day 11.5, and p72-null mice are postnatal lethal. miRNA
expression analysis of null embryos indicated reduced
mature miRNA levels. Whether the reduction of these
miRNAs was due to loss of function in the respective
helicase, or whether the mutant phenotype led to aber-
rant miRNA expression due to developmental alter-
ations, remains to be addressed. However, mouse embry-
onic fibroblasts (MEFs) derived from p72-null embryos
had a reduction in at least two miRNAs (miR-16 and mir-
145), but not all miRNAs, and this reduction could
be rescued by introduction of ectopic p72. pri-miRNA
expression was unaffected, demonstrating an alteration
in processing of the miRNA precursors. Interestingly,
ATPase mutant alleles of p72 did not rescue production of
either miR-16 or miR-145. This is in contrast to the
transcriptional coactivation role for p68, which was not
dependent on helicase activity. Therefore, for at least
these two miRNAs, a role for helicase activity (or possibly
ATP-dependent conformation change) is required. Fur-
thermore, cell-free extracts that lack either p68 or p72 are
inefficient at conversion of pri-miR-16 to the correspond-
ing precursor miRNA. RNA immunoprecipitation (RIP)
experiments in the same study showed that Drosha
recruitment to pri-miR-199a and pri-miR-214 was lost
upon RNAi-mediated depletion of p68 or in p72 knockout
cells, consistent with the observation that mature miR-
199a and miR-214 levels are lower in p68/p72-null em-
bryos. Thus, in vivo, these helicases seem to be required to
properly recruit the Microprocessor to some pri-miRNAs.
As discussed below, it is now clear that multiple critical
cellular signaling pathways use the p68 and p72 associa-
tion with Microprocessor to effect regulation of pri-
miRNA processing.
Transforming growth factor b/bone morphogenic
protein (TGF-b/BMP)
The first study to report a signal transduction-mediated
change in miRNA biogenesis demonstrated that the
TGF-b and BMP pathways specifically promote process-
ing of pri-miR-21 (Davis et al. 2008). The contractile phe-
notype of human smooth muscle cells treated with
TGF-b or BMP was found to be dependent on the rapid up-
regulation of miR-21. Interestingly, this rapid increase in
miR-21 occurred post-transcriptionally; quantitative real-
time PCR (qRT–PCR) experiments revealed that pre-miR-
21 and mature miR-21 levels quickly increased upon
TGF-b and BMP treatment, while levels of pri-miR-21
were unchanged. Davis et al. (2008) then reasoned that
SMAD proteins might be the intermediaries responsible
for connecting these signaling pathways with miR-21
processing, as they are translocated into the nucleus upon
TGF-b or BMP signaling and are known to bind DNA.
Furthermore, a previous study reported that SMAD1 in-
teracts directly with the RNA helicase p68 (Warner et al.
2004). Accordingly, depletion of receptor-specific SMADs
(SMAD1 and SMAD5) or p68 abrogated the BMP and
TGF-b-driven increase in pri-miR-21 processing. Some
initial mechanistic insight was also provided; GST pull-
downs with recombinant SMADs in nuclear extracts in-
dicated that p68 binds to the MH2 domain of R-SMADs
while the MH1 domain binds to pri-miR-21 either di-
rectly or through other unknown factors.
The full complement of miRNAs that are regulated by
this pathway is presently unknown. Since the TGF-b and
BMP signaling pathways regulate many biological phe-
nomena, it is possible that these pathways stimulate
processing of other pri-miRNAs; indeed, Davis et al.
(2008) also observed that pri-miR-199a processing is reg-
ulated in this manner. This is not surprising, since these
signaling pathways converge on miRNA processing via
p68, and this helicase has been shown to modulate a
number of miRNAs.
The p53 DNA damage pathway
Unexpectedly, a subsequent study demonstrated that the
tumor suppressor p53 also promotes pri-miRNA process-
ing. It was noted that many miRNAs depleted in p72
knockout mice are coincidentally also up-regulated by
the DNA-damaging agent Doxorubicin (Dox). As Dox
strongly stimulates p53 activity, leading to induction of
p53-responsive genes, it was perhaps not surprising that
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p53 might also induce the expression of miRNAs. In fact,
miR-34 had been well established as a direct p53 tran-
scriptional target (He et al. 2007). However, after mea-
suring pri-miRNA expression levels of induced miRNAs,
Suzuki et al. (2008) realized that these miRNAs were not
being induced transcriptionally. Rather, processing at
the Drosha step was triggered. In hindsight, this was
not so surprising: p68 was known to regulate pri-miRNA
processing, and the helicase had been shown to interact
with p53 as a coactivator; ergo, p53 might be able to
directly modulate miRNA processing (Bates et al. 2005).
Accordingly, coimmunoprecipitation experiments as well
as in vitro Drosha processing assays demonstrated that
p53 associated with the large Drosha complex upon
treatment of cells with Dox. Intriguingly, p53 alleles with
known oncogenic activity decreased processing effi-
ciency of p53-targeted miRNAs by disrupting p68’s asso-
ciation with Drosha, thus displacing the Drosha complex
from selected pri-miRNAs. Again, the biochemical basis
of p53’s association with p68 and the subsequent increase
in target pri-miRNA processing remains obscure. De-
tailed structure–function studies will be needed to un-
derstand how p68 binding to p53 (both wild-type and
oncogenic alleles) modulates Drosha’s ability to process
pri-miRNAs.
ERa/estrogen
Another interesting report revealed how a signaling cas-
cade can negatively regulate pri-miRNA processing. Kato
and colleagues (Endoh et al. 1999) noticed that ERa was
shown previously to interact with p68 and p72. Augmen-
tation of the ERa signaling pathway produced a striking
pattern of changes in certain miRNAs; many miRNAs
were increased in ERa/mice (Yamagata et al. 2009). Fur-
thermore, administration of estradiol (E2) to ovariecto-
mized mice reduced the same miRNAs within the uterus.
Importantly, this effect of E2/ERa could be recapitulated in
the human breast cancer cell line MCF7. The physiolog-
ical importance of ERa-regulated miRNA biogenesis was
evident from the observation that the 39 untranslated
region (UTR) of VEGF, an ERa target gene, is targeted by
ERa-repressed miRNAs. Yamagata et al. (2009) then dem-
onstrated in vitro that E2-bound ERa could directly inhibit
Drosha processing of ERa target pri-miRNAs. This study
delved into more biochemical detail than the reports
mentioned above: It was determined that p68 and/or p72
bridge the interaction between Drosha and E2-bound ERa;
this interaction requires the C-terminal domain of Drosha
and the N terminus of ERa. Thus, when ERa is recruited
to the large Drosha complex in an E2-dependent manner,
Drosha is dissociated from ERa-targeted pri-miRNA
loci. It will be interesting to determine whether ERa/E2
weakens the overall integrity of the large Drosha com-
plex, or simply its affinity for certain pri-miRNAs.
A pri-miRNA processing holoenzyme? Facts
and future directions
As mentioned above, Drosha isolated from mammalian
extracts exists in a large complex with many different
RNA-binding proteins. The role of most of these Drosha-
associated factors in pri-miRNA processing is not clear. It
seems entirely possible that many of the factors purified
in the large cellular Drosha complex may be the result
of a nonphysiological RNA–protein complex assembled
upon cell lysis. In support of this, while the dsRNA-
binding proteins NFAT-90 and NFAT-45 were shown pre-
viously to be Drosha-associated factors (Gregory et al.
2004), one recent study showed that this heterodimer
does not interact with Drosha and, in fact, inhibits
processing of certain pri-miRNAs (Gregory et al. 2004;
Sakamoto et al. 2009). This study underscores the need to
more carefully analyze the functional interactions be-
tween Drosha–DGCR8 and the many auxiliary factors
that are contained within the large complex. As with p68
and p72, there may indeed be important roles for other
Drosha-associated factors, as general Microprocessor co-
factors or as factors that integrate specific cell signaling
pathways with pri-miRNA processing.
So, does Drosha/DGCR8 function within the context
of a larger holoenzyme in vivo? The studies mentioned
above suggest that, of the Drosha-associated factors
initially identified, p68 and p72 are the first to be assigned
as important cofactors in Drosha processing of certain pri-
miRNAs. Taken together, the aforementioned studies
suggest a model shown in Figure 1. Drosha processing is
known to occur cotranscriptionally (Kim et al. 2009). p68
has been proposed to link mRNA transcription to splicing
(Fuller-Pace and Ali 2008). Therefore, p68 and/or p72
might perform a similar function with miRNAs. That is,
p68 might act as a bridge between the Microprocessor and
specific miRNAs, at the RNA polymerase holoenzyme
during transcription. This effect might be independent of
helicase activity, as is the role of p68 in mRNA transcrip-
tional events. However, p72 activation of miR-16 and miR-
145 processing is ATP-dependent, suggesting a second,
helicase-dependent role for p72 (Fukuda et al. 2007). This is
further supported by the fact that p72 modulates Micro-
processor function in cell-free extracts that is unlinked
to transcription. It is important to note that all of these
cell-free assays are based on crude extracts or on partially
purified components. Without an exact understanding of
the protein composition of the assays, it is difficult to fully
understand the role of these accessory proteins.
It’s all in the loop: specific interactions between
regulatory proteins and the terminal loop
of miRNA precursors
As discussed above, one mode of regulated miRNA bio-
genesis occurs through modulation of Microprocessor
activity. A second regulatory phenomenon occurs when
RNA-binding proteins bind directly to specific sequences
within pri-miRNAs, diverting the RNA away from bio-
genesis events, and often leading to degradation of the
RNA.
Lin28 as a master regulator of let-7 production
let-7 is one of the most abundant miRNA families in
mammals, with high expression in essentially all adult
Newman and Hammond
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tissues. In embryonic cells, in contrast, mature let-7 is
present at ;1000-fold lower levels. Unexpectedly, pri-let-7
expression is constant throughout development, thus
providing a dramatic illustration of post-transcriptional
regulation of a miRNA (Thomson et al. 2006). Research
published over the past 2 years has demonstrated that
the RNA-binding protein Lin28 blocks let-7 miRNA
maturation in early embryonic cells, and the related
Lin28B contributes to let-7 reduction in cancer (for re-
view, see Viswanathan and Daley 2010). Initial studies
demonstrated that Lin28 represses Drosha and Dicer
processing of let-7 in vitro by binding to conserved se-
quences in the precursor loop. Furthermore, overexpres-
sion of Lin28 in differentiated cells and knockdown of
Lin28 in embryonic cells resulted in the depletion and
accumulation of mature let-7, respectively. The exact
mechanism whereby Lin28 blocks processing steps is un-
known. What was clear is that the blocked pri-miRNA/
pre-miRNA was not accumulating in cells, suggesting
a turnover mechanism. We now know, in the case of the
pre-let-7, that Lin28 directly recruits a poly(U) polymer-
ase, terminal (U) transferase (TUT4), to the precursor
RNA (Hagan et al. 2009; Heo et al. 2009; Lehrbach et al.
2009). Oligo-uridylation of the precursor occurs, which
triggers degradation. The fate of the blocked pri-let-7 is
still unknown (see Fig. 2).
The story of Lin28 thus comes full circle. This embry-
onic stem (ES) cell-specific RNA-binding protein was one
of the earliest-recognized let-7 targets (Reinhart et al.
2000). In embryonic development, its expression is re-
ciprocal to that of mature let-7. Concordantly, Lin28 over-
expression, in combination with several ES-specific tran-
scription factors, is sufficient to reprogram somatic cells
into induced pluripotent stem (iPS) cells (Yu et al. 2007).
KH-type splicing regulatory factor (KSRP) binds let-7
loop sequences and activates miRNA processing
Recently, a role was uncovered for the RNA-binding
protein KSRP in promoting miRNA biogenesis in mam-
mals (Trabucchi et al. 2009). This protein binds specifi-
cally to 59guanosine-rich patches on the loop region of
several miRNA precursors, including let-7. Knockdown
of KSRP significantly decreases the expression of these
miRNAs, in part by preventing efficient recruitment of
Drosha and Dicer to the pri-miRNA and pre-miRNA,
respectively. The obvious question is: How can Lin28 and
KSRP bind to the let-7 loop, but with opposing terminal
outcomes? Interestingly, while recombinant fragments
of KSRP bind to the let-7 terminal loop with high affinity
in vitro, KSRP cannot bind to pri-let-7 in embryonic
cells, which have abundant Lin28. This suggests a model
whereby Lin28 and KSRP bind in a mutually exclusive
manner. Specifically, Lin28 may sterically hinder KSRP
binding even though the two proteins bind to unique se-
quences on opposites sides of the let-7 loop. Alternatively,
an unidentified factor in embryonic cells could bind co-
operatively with Lin28 to let-7 loops, thereby preventing
KSRP binding.
Regulation of miRNA processing by hnRNP proteins
While the above examples point to regulators with spe-
cific functions, there are other examples of RNA-binding
proteins with a pleiotropic function in RNA biogenesis.
One such example is the highly abundant RNA-binding
protein hnRNP A1. This protein has been well estab-
lished as a component of many hnRNPs and performs
essential functions in many RNA processing and trans-
port pathways (He and Smith 2009). Using cross-linking
Figure 1. Model for regulation of miRNA biogenesis at the Microprocessor. Multiple signaling pathways converge on the Micro-
processor via the helicases p68 and p72. These helicases have ATP-dependent and ATP-independent functions. We present a model
whereby both functions affect miRNA production. The ATP-independent functions have been linked with recruitment of processing
activities to RNA polymerase. This could be used by the miRNA pathway as a manner of recruitment of the Microprocessor to
transcription sites. The ATP-dependent role of p68 has been described as maintenance of proper RNA secondary structure to facilitate
Drosha cleavage. The components of the RNA polymerase preinitiation complex and Microprocessor are simplified. (TBP) TATA-
binding protein; (TAF) TBP-associated factors; (InR) initiator element; (RE) response element.
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immunoprecipitation (CLIP) (Ule et al. 2005), Guil and
Caceres (2007) demonstrated that hnRNP A1 interacts
with specific nucleotides of the loop and stem of pri-
miR-18a. This miRNA is one of six miRNA stem–loops
on the oncogenic polycistron miR-17-92. The role for
hnRNP A1 in miRNA processing was demonstrated
when HeLa extracts depleted of hnRNP A1 by RNAi
failed to process pri-miR-18a from pri-miR-17-92, while
the other pri-miRNAs in the polycistron were still
processed. Interestingly, when recombinant hnRNP A1
was added back to the depleted extract, pri-miR-18a
processing was not restored; this suggests that hnRNP A1
might have to be ‘‘precomplexed’’ with other RNA-
binding factors in order to act specifically on pri-miR-
18a. Of course, it is also possible that bacterially purified
hnRNP A1 is missing post-translational modifications
that are required for the positive regulation of pri-miR-
18a processing.
Further studies demonstrated that hnRNP A1 binding
to the loop and stem regions of pri-miR-18a relaxes
the stem region and facilitates cleavage by Drosha. Bioin-
formatic analysis and RNA affinity purification using
miRNA loop sequences, as well as in vitro Drosha as-
says, revealed that many hnRNP proteins could poten-
tially form an extensive interaction network with
miRNA loops (Michlewski et al. 2008). Thus, hnRNPs
may broadly control the levels of miRNAs at the post-
transcriptional level. The general physiological functions
of hnRNP–miRNA loop interactions remain to be eluci-
dated; ultimately, it will be important to understand the
global distribution of hnRNP proteins between miRNAs
and non-miRNA-containing substrates.
Contrasting mechanisms allow fine-tuned expression
of miRNAs
We discussed two paradigms for regulated miRNA bio-
genesis. Control at the Microprocessor allows integra-
tion of signaling events from many pathways, leading to
changes in expression of divergent miRNA families. All
of the discussed events are mediated by the helicases p68
and p72. In many cases, the regulated miRNA families are
similar, but there are notable exceptions. So how does
this pathway allow specificity? Some interaction with the
pri-miRNA must confer specificity. In the case of SMAD
regulation of miR-21 processing, specificity could arise
from interaction of the pri-miRNA with the SMAD-
interacting protein SNIP1. This coactivator protein had
independently been shown to affect miRNA processing,
and its Arabidopsis homolog has direct RNA-binding
activity (Yu et al. 2008). In other cases, the key regulatory
protein might itself interact with the pri-miRNA. As
an example, p53 can immunoprecipitate pri-miR-16; but
is there a direct interaction between p53 and the pri-
miRNA, or is it bridged by p68? Interestingly, many
transcription factors, including p53, have been shown
to have RNA-binding activity (Riley and Maher 2007).
Such interactions may provide the critical specificity. Of
course, unidentified proteins may be part of the Micropro-
cessor, possibly as a transient complex assembled after
signal reception. Clearly, to fully understand this complex,
we need better characterization of components, and ulti-
mately reconstitution in defined activity assays. In con-
trast with the Microprocessor paradigm, the loop-binding
regulators clearly have a mechanism for specificity. In the
Figure 2. Model for regulation of miRNA biogenesis by
loop-binding proteins. The processing of let-7 is shown,
with contrasting effects of an inhibitor (Lin28) and an
activator (KSRP). Both regulators have been linked to the
Drosha and Dicer step. In addition, Lin28 promotes deg-
radation of the precursor. Degradation of pri-let-7 has not
been demonstrated; however, pri-let-7 does not accumu-
late in the presence of Lin28 blockade, and therefore may
be actively degraded. (TUT4) terminal (U) transferase;
(KSRP) KH-type splicing regulatory factor.
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case of Lin28, the expression of that regulator is confined
to the stem cell compartment, providing an obvious mech-
anism of control. KSRP and the various hnRNP proteins,
in contrast, are widely expressed. Their biological function
in the miRNA pathway is still poorly understood.
In addition to these paradigms, other regulatory events
during miRNA biogenesis have been described, but could
not be included in this review. For example, the metab-
olite heme can modulate Microprocessor function, al-
though the biological role of this effect is unclear (Faller
et al. 2007). The nuclear cap-binding complex component
ARS2 is important for fidelity of Microprocessor cleavage
(Gruber et al. 2009). The miRNA primary sequence can
be altered by A–I editing, leading to altered processing and
function (Yang et al. 2006). When taken into consider-
ation, it is clear that miRNA processing is regulated in
a complex manner, and we are only beginning to under-
stand its true nature.
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